Skip to main content
SpringerLink
Log in

Rescuing Canavan disease: engineering the wrong cell at the right time

  • Editorial
  • Published:
Journal of Inherited Metabolic Disease

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Baslow MH (2000) Functions of N-acetyl-L-aspartate and N-acetyl-L-aspartylglutamate in the vertebrate brain. Role in glial cell-specific signaling. J Neurochem 75:453–459

    Article  CAS  PubMed  Google Scholar 

  • Baslow MH, Guilfoyle DN (2009) Are astrocytes the missing link between lack of brain aspartoacylase activity and the spongiform leukodystrophy in Canavan disease? Neurochem Res 34:1523–1534

    Article  CAS  PubMed  Google Scholar 

  • Baslow MH, Guilfoyle DN (2016) Evidence that N-acetylaspartylglutamate is the astrocyte-targeted neurovascular coupling agent that regulates slow tonic control of brain blood flow. J Glycomics Metab 1(1):1–12

    Article  Google Scholar 

  • Baslow MH, Suckow R, Sapirstein V, Hungund BL (1999) Expression of aspartoacylase activity in cultured rat macroglial cells is limited to oligodendrocytes. J Mol Neurosci 13:47–53

    Article  CAS  PubMed  Google Scholar 

  • Gessler DJ, Li D, Xu H, Su Q, Sanmiguel J, Tuncer S, Moore C, King J, Matalon R, Gao G (2017) Redirecting N-acetylaspartate metabolism in the central nervous system normalizes myelination and rescues Canavan disease. JCI Insight. doi:10.1172/jci.insight.90807

    PubMed  PubMed Central  Google Scholar 

  • Martin E, Capone A, Schneider J, Hennig J, Thorsten T (2001) Absence of N-acetylaspartate in the human brain: Impact on neurospectroscopy ? Ann Neurol 49:518–521

    Article  CAS  PubMed  Google Scholar 

  • Waime E, Tyteca D, Pierrot N, Collard F, Amyere M, Noel G, Desmedt J, Nassogne M-C et al (2010) Molecular identification of aspartate N-acetyltransferase and its mutation in hypoacetylaspartia. Biochem J 425:127–136

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center for Biomedical Imaging and Neuromodulation, Nathan Kline Institute for Psychiatric Research, 140 Old Orangeburg Road, Orangeburg, NY, 10962, USA

    Morris H Baslow

Authors
  1. Morris H Baslow
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Morris H Baslow.

Ethics declarations

This article does not contain any studies with human or animal subjects performed by the author.M.H. Baslow planned and wrote the article.

Conflict of interest

M.H. Baslow has no conflict of interest.

Additional information

Communicated by: Ertan Mayatepek

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Baslow, M.H. Rescuing Canavan disease: engineering the wrong cell at the right time. J Inherit Metab Dis 40, 627–628 (2017). https://doi.org/10.1007/s10545-017-0038-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10545-017-0038-2

Keywords

Search

Navigation